Keywords: synergen, future, appears, rocky, after, antril, failure

Synergen's Future Appears Rocky After Antril Failure

Article | 25 July 1994

Print This

Synergen has stopped its follow-up trial of Antril (anakinra) for severe sepsis, after an interim analysis of data showed a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in